$RGBP Agreed, GM. I think we have a very solid pl
Post# of 102231
For those not yet up to speed with RegenBiopharma Inc., I would strongly suggest checking out our board:
http://investorshangout.com/Regen-BioPharma-Inc-RGBP-90534/
In the works:
2 FDA Approvals:
#1) Hemaxellerate - Therapeutic for aplastic anemia; may receive orphan drug designation; Shown to have no toxicity at ten times therapeutic dose; FDA requested Good Laboratory Practices Study; Study completed by Charles River Labs, confirms safety/toxicity data originally sent; green light expected.
#2) dCellVax - Onco-immuno therapeutic vaccine for breast cancer; link to Bristol Myers Squibb, leader of onco-immune therapies to date; Bristol Myers Sqibb logo accompanying dCellVax logo on company website under the product pipeline tab; currently in front of FDA
Scientific Advisory Board:
http://www.prnewswire.com/news-releases/regen...90921.html
...and a whole lot more!